Economic burden of hypoglycemia for type II diabetes mellitus patients in Malaysia

Abstract

This study mainly aims to identify the direct cost and economic burden of hypoglycemia for patients with type II diabetes mellitus in Malaysia. A cross-sectional study explored the cost incurred for hypoglycemia among patients admitted to University Kebangsaan Malaysia Medical Centre (UKMMC). The study covered patients aged 20–79 years hospitalized with a primary diagnosis of ICD-10 hypoglycemia and discharged between January 2010 and September 2015 according to the casemix database. A costing analysis was done through a step-down approach from the perspective of health providers. Cost data were collected for three levels of cost centers with the help of a hospital-costing template. The costing data from UKMMC were used to estimate the national burden of hypoglycemia among type II diabetics for the whole country. Of 244 diabetes patients admitted primarily for hypoglycemia to UKMMC, 52% were female and 88% were over 50 years old. The cost increased with severity. Managing a hypoglycemic case requires five days (median) of inpatient stay on average, with a range of 2–26 days, and costs RM 8,949 (USD 2,289). Of the total cost, 30% related to ward (final cost center), 16% to ICU, and 15% to pharmacy (secondary-level cost center) services. Considering that 3.2% of all admissions were hypoglycemia related, the total annual cost of hypoglycemia care for adult diabetics in Malaysia is estimated at RM 117.4 (USD 30.0) million, which translates to 0.5% of the Ministry of Health budget. Hypoglycemia imposes a substantial economic impact even without the direct and indirect cost incurred by patients and other cost of complications. Diabetic management needs to include proper diabetic care and health education to reduce episodes of hypoglycemia.

Diabetic retinopathy among type 2 diabetes mellitus patients in Sabah primary health clinics–Addressing the underlying factors

“…In addition, the data in 2015 highlighted that 8.8% of the adults in Southeast Asia had T2DM. In Malaysia, the prevalence of T2DM was 0.94 million in 2000 and the number is expected to increase by 164.0% to 2.48 million in 2030 [2]. In Peninsular Malaysia, the risk of Diabetic Retinopathy (DR) was higher among Malays compared to other races [3].…”

Health Care Utilization and Out-of-Pocket Payments among Elderly with Cognitive Frailty in Malaysia

“…It is well known that private health care is considered more expensive compared to public health care services. For Malaysians, it is worth mentioning that Malaysian public health care facilities provide highly subsidized inpatient and outpatient health care services to its citizens [ 105 ]. This would affect the total OOP payments of elderly Malaysians seeking health care in general; these high governmental subsidizations can lead to reduced total OOP payments compared to those observed in other countries.…”

Performance Analysis of Conventional Machine Learning Algorithms for Diabetic Sensorimotor Polyneuropathy Severity Classification

“…According to the International Diabetic Federation [ 1 ] in 2019 almost 463 million people are affected with diabetes and 50% of the total prevalence is suffering from DSPN. USD 760 million is spent on diabetics and the health expenditure for diabetic patients increases with severity [ 1 , 51 ]. By enhancing the awareness among patients about DSPN as well as the performance of the diagnosis methods will help to improve the healthcare facilities for diabetic patients.…”